Gómez Sergio Y, Ocazionez Raquel E
Centro de Investigaciones en Enfermedades Tropicales, Universidad Industrial de Santander, Bucaramanga, Colombia.
Rev Salud Publica (Bogota). 2008 Nov-Dec;10(5):796-807. doi: 10.1590/s0124-00642008000500012.
Determining the frequency of yellow fever seroprotective antibody neutralising titres (YF-NT >or=1:10) in Colombians vaccinated with the 17 D virus and ascertaining the extent to which YF virus can be neutralised by dengue antibodies.
Serum samples were taken from 100 subjects who showed their vaccination record and from 116 residents in municipalities (Norte de Santander) affected by a wild YF outbreak in 2002-2003 who were reported to have been YF vaccinated. Sera from individuals with (n=61) and without (n=16) dengue antibodies who had never been YF vaccinated were included. All the sera were tested by 75 % YF plaque-reduction neutralization test.
YF-NT titres >or=1:10 were founded in 90 % of subjects with vaccination recorded with minors variations in relation to age. In contrast, there was correlation between decrease of seroprotective YF-NT titres frequency and increase of immunization time (r=0.95; p=0.04). In residents in YF endemic area, YF-NT titres >or= 1.10 were founded in 92,6 % adults and 69 % children. YF 17 D virus was neutralized (52-100 %) by dengue sera more efficiently than non-dengue immune sera (p<0.001).
Individuals immunised with YF vaccine 17 D could not be protected against YF: up to 31% children and 10 % adults. Dengue antibodies inhibited YF virus and its significance in terms of YF protection must be investigated.
确定接种17D病毒疫苗的哥伦比亚人中黄热病血清保护性抗体中和效价(黄热病毒中和效价≥1:10)的频率,并确定登革热抗体对黄热病毒的中和程度。
从100名出示疫苗接种记录的受试者以及2002 - 2003年受黄热病野生疫情影响的市镇(北桑坦德省)的116名居民中采集血清样本,这些居民据报告已接种黄热病疫苗。纳入了从未接种过黄热病疫苗但有(n = 61)和没有(n = 16)登革热抗体的个体的血清。所有血清均通过75%黄热病毒蚀斑减少中和试验进行检测。
在90%有疫苗接种记录的受试者中发现黄热病毒中和效价≥1:10,且与年龄有微小差异。相比之下,血清保护性黄热病毒中和效价频率的降低与免疫时间的增加之间存在相关性(r = 0.95;p = 0.04)。在黄热病流行地区的居民中,92.6%的成年人和69%的儿童黄热病毒中和效价≥1:10。登革热血清比非登革热免疫血清更有效地中和黄热17D病毒(52 - 100%)(p < 0.001)。
接种黄热病17D疫苗的个体无法得到对黄热病的保护:高达31%的儿童和10%的成年人。登革热抗体抑制黄热病毒,其在黄热病保护方面的意义必须进行研究。